140 related articles for article (PubMed ID: 21958858)
1. Pharmacokinetics, dosimetry and comparative efficacy of 188Re-liposome and 5-FU in a CT26-luc lung-metastatic mice model.
Chen LC; Wu YH; Liu IH; Ho CL; Lee WC; Chang CH; Lan KL; Ting G; Lee TW; Shien JH
Nucl Med Biol; 2012 Jan; 39(1):35-43. PubMed ID: 21958858
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics, micro-SPECT/CT imaging and therapeutic efficacy of (188)Re-DXR-liposome in C26 colon carcinoma ascites mice model.
Chen LC; Chang CH; Yu CY; Chang YJ; Wu YH; Lee WC; Yeh CH; Lee TW; Ting G
Nucl Med Biol; 2008 Nov; 35(8):883-93. PubMed ID: 19026950
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic efficacy and microSPECT/CT imaging of 188Re-DXR-liposome in a C26 murine colon carcinoma solid tumor model.
Chang YJ; Chang CH; Yu CY; Chang TJ; Chen LC; Chen MH; Lee TW; Ting G
Nucl Med Biol; 2010 Jan; 37(1):95-104. PubMed ID: 20122674
[TBL] [Abstract][Full Text] [Related]
4. Biodistribution and pharmacokinetics of 188Re-liposomes and their comparative therapeutic efficacy with 5-fluorouracil in C26 colonic peritoneal carcinomatosis mice.
Tsai CC; Chang CH; Chen LC; Chang YJ; Lan KL; Wu YH; Hsu CW; Liu IH; Ho CL; Lee WC; Ni HC; Chang TJ; Ting G; Lee TW
Int J Nanomedicine; 2011; 6():2607-19. PubMed ID: 22114492
[TBL] [Abstract][Full Text] [Related]
5. Comparative therapeutic efficacy of rhenium-188 radiolabeled-liposome and 5-fluorouracil in LS-174T human colon carcinoma solid tumor xenografts.
Hsu CW; Chang YJ; Chang CH; Chen LC; Lan KL; Ting G; Lee TW
Cancer Biother Radiopharm; 2012 Oct; 27(8):481-9. PubMed ID: 23067100
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the therapeutic efficacy of 188Rhenium-liposomes and liposomal doxorubicin in a 4T1 murine orthotopic breast cancer model.
Liu CM; Lee WC; Yu CY; Lan KL; Chang CH; Ting G; Lee TW
Oncol Rep; 2012 Mar; 27(3):678-84. PubMed ID: 22109644
[TBL] [Abstract][Full Text] [Related]
7. Biodistribution and therapeutic efficacy of (125/131)I-, (186)Re-, (88/90)Y-, or (177)Lu-labeled monoclonal antibody MN-14 to carcinoembryonic antigen in mice with small peritoneal metastases of colorectal origin.
Koppe MJ; Bleichrodt RP; Soede AC; Verhofstad AA; Goldenberg DM; Oyen WJ; Boerman OC
J Nucl Med; 2004 Jul; 45(7):1224-32. PubMed ID: 15235070
[TBL] [Abstract][Full Text] [Related]
8. MicroSPECT/CT imaging and pharmacokinetics of 188Re-(DXR)-liposome in human colorectal adenocarcinoma-bearing mice.
Chen MH; Chang CH; Chang YJ; Chen LC; Yu CY; Wu YH; Lee WC; Yeh CH; Lin FH; Lee TW; Yang CS; Ting G
Anticancer Res; 2010 Jan; 30(1):65-72. PubMed ID: 20150618
[TBL] [Abstract][Full Text] [Related]
9. Comparative dosimetric evaluation of nanotargeted (188)Re-(DXR)-liposome for internal radiotherapy.
Chang CH; Stabin MG; Chang YJ; Chen LC; Chen MH; Chang TJ; Lee TW; Ting G
Cancer Biother Radiopharm; 2008 Dec; 23(6):749-58. PubMed ID: 19111045
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of 188Re-labeled PEGylated nanoliposome as a radionuclide therapeutic agent in an orthotopic glioma-bearing rat model.
Huang FY; Lee TW; Chang CH; Chen LC; Hsu WH; Chang CW; Lo JM
Int J Nanomedicine; 2015; 10():463-73. PubMed ID: 25624760
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the therapeutic and diagnostic effects of PEGylated liposome-embedded 188Re on human non-small cell lung cancer using an orthotopic small-animal model.
Lin LT; Chang CH; Yu HL; Liu RS; Wang HE; Chiu SJ; Chen FD; Lee TW; Lee YJ
J Nucl Med; 2014 Nov; 55(11):1864-70. PubMed ID: 25349220
[TBL] [Abstract][Full Text] [Related]
12. 186Re-liposome labeling using 186Re-SNS/S complexes: in vitro stability, imaging, and biodistribution in rats.
Bao A; Goins B; Klipper R; Negrete G; Phillips WT
J Nucl Med; 2003 Dec; 44(12):1992-9. PubMed ID: 14660726
[TBL] [Abstract][Full Text] [Related]
13. The PEGylated liposomal doxorubicin improves the delivery and therapeutic efficiency of 188Re-Liposome by modulating phagocytosis in C26 murine colon carcinoma tumor model.
Hsu WH; Liu SY; Chang YJ; Chang CH; Ting G; Lee TW
Nucl Med Biol; 2014 Oct; 41(9):765-71. PubMed ID: 25027866
[TBL] [Abstract][Full Text] [Related]
14. An analytic dosimetry study for the use of radionuclide-liposome conjugates in internal radiotherapy.
Emfietzoglou D; Kostarelos K; Sgouros G
J Nucl Med; 2001 Mar; 42(3):499-504. PubMed ID: 11337529
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic efficacy of a 188Re-labeled alpha-melanocyte-stimulating hormone peptide analog in murine and human melanoma-bearing mouse models.
Miao Y; Owen NK; Fisher DR; Hoffman TJ; Quinn TP
J Nucl Med; 2005 Jan; 46(1):121-9. PubMed ID: 15632042
[TBL] [Abstract][Full Text] [Related]
16. Dosimetry of 188Re-hydroxyethylidene diphosphonate in human prostate cancer skeletal metastases.
Liepe K; Hliscs R; Kropp J; Runge R; Knapp FF; Franke WG
J Nucl Med; 2003 Jun; 44(6):953-60. PubMed ID: 12791825
[TBL] [Abstract][Full Text] [Related]
17. Biodistribution, pharmacokinetics and imaging of (188)Re-BMEDA-labeled pegylated liposomes after intraperitoneal injection in a C26 colon carcinoma ascites mouse model.
Chen LC; Chang CH; Yu CY; Chang YJ; Hsu WC; Ho CL; Yeh CH; Luo TY; Lee TW; Ting G
Nucl Med Biol; 2007 May; 34(4):415-23. PubMed ID: 17499731
[TBL] [Abstract][Full Text] [Related]
18. Dosimetric evaluation of nanotargeted (188)Re-liposome with the MIRDOSE3 and OLINDA/EXM programs.
Chang CH; Chang YJ; Lee TW; Ting G; Chang KP
Ann Nucl Med; 2012 Jun; 26(5):419-25. PubMed ID: 22450826
[TBL] [Abstract][Full Text] [Related]
19. Preliminary evaluation of acute toxicity of (188) Re-BMEDA-liposome in rats.
Liu CM; Chang CH; Chang YJ; Hsu CW; Chen LC; Chen HL; Ho CL; Yu CY; Chang TJ; Chiang TC; Lee TW
J Appl Toxicol; 2010 Oct; 30(7):680-7. PubMed ID: 20981861
[TBL] [Abstract][Full Text] [Related]
20. 5-Fluorouracil dose escalation enabled with PN401 (triacetyluridine): toxicity reduction and increased antitumor activity in mice.
Saif MW; von Borstel R
Cancer Chemother Pharmacol; 2006 Jul; 58(1):136-42. PubMed ID: 16187114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
